Presentation TCT 2022 PCI in Patients With AF: The Risk and Benefit of Antithrombotic Therapy Presenter: Usman Baber September 18, 2022
Presentation TCT 2021 DAPT Duration in the Afib Patient: Where Do We Stand? Presenter: Renato Lopes November 05, 2021
Presentation TCT 2021 DAPT Duration in High Bleeding Risk Patients: Lessons From RCTs Presenter: Marco Valgimigli November 05, 2021
Presentation TCT 2021 DAPT Duration in High Bleeding Risk Patients: Lessons From Registries Presenter: Davide Cao November 05, 2021
Presentation Switching of OAC After PCI in A-fib Patients:RE-DUAL PCI Trial Subanalysis December 04, 2019
Presentation ACC 2019 Apixaban vs VKA and Aspirin vs Placebo in Patients with Atrial Fibrillation and ACS/PCI: The AUGUSTUS Trial Presenter: Renato Lopes March 18, 2019
Presentation The Structural Heart Disease Summit 2018 Atrial Fibrillation + PCI: The Myths and Realities of Triple Therapy Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Ashish Pershad June 22, 2018
Presentation Discrepancy Between Physician Perception, Objective Risks in A-fib Patients Undergoing PCI April 27, 2018
Presentation TCT 2017 Case #2 Resolution: How We Treated a High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Complex Multi-stent PCI or Any PCI for ACS Presenter: Renato D. Lopes, David J. Moliterno, Sheila Sahni November 01, 2017
Presentation TCT 2017 Case #2 Introduction: High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Complex Multi-stent PCI or Any PCI for ACS Presenter: Renato D. Lopes, David J. Moliterno, Sheila Sahni November 01, 2017
Presentation TCT 2017 Case #1 Resolution: How We Treated a High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Non-Complex PCI for Stable CAD Presenter: Renato D. Lopes, David J. Moliterno, Amit N Vora November 01, 2017
Presentation TCT 2017 Case #1 Introduction: High Bleeding-Risk Patient With Chronic Atrial Fibrillation Undergoing Non-Complex PCI for Stable CAD Presenter: Renato D. Lopes, David J. Moliterno, Amit N Vora November 01, 2017
Presentation TCT 2017 Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS? Presenter: Samir R. Kapadia, Ioanna Kosmidou November 01, 2017
Presentation TCT 2017 Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic Atrial Fibrillation Patient Who Requires PCI Presenter: Robert A. Harrington, Kurt Huber, Christopher B. Granger November 01, 2017
Presentation TCT 2017 Guidelines and Expert Consensus on Anticoagulation in the Atrial Fibrillation Patient With ACS or PCI: How Strong Is the Evidence? Presenter: Robert A. Harrington, Kurt Huber, Jean-François Tanguay November 01, 2017
Presentation TCT 2017 The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus Antiplatelet Therapy Presenter: Robert A. Harrington, Kurt Huber, Renato D. Lopes November 01, 2017
Presentation TCT 2016 The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status Presenter: Freek W.A. Verheugt, Pascal Vranckx, Deepak L. Bhatt November 01, 2016
Presentation TCT 2016 The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI: Design, Rationale, and Status Presenter: Freek W.A. Verheugt, Pascal Vranckx, Roxana Mehran November 01, 2016
Presentation TCT 2016 The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status Presenter: Freek W.A. Verheugt, Pascal Vranckx November 01, 2016
Presentation TCT 2016 The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status Presenter: Freek W.A. Verheugt, Pascal Vranckx, C. Michael Gibson November 01, 2016